HIGHLIGHTS
- who: Guido Rovera and colleagues from the A retrospective analysis was conducted on four hundred forty-three (443) consecutive scans performed between November , and December , at our institution (Department of Nuclear Medicine, University Hospital of Turin) in HSPC patients with early biochemical recurrence/persistence, according to the GuidelinesInclusion criteria were: (1) histologically proven PCa have published the article: Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence, in the Journal: Diagnostics 2022, 12, 1309. of 20/03/2008
- what: This study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.